Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

IL-17 enhancement of the IL-6 signaling cascade in astrocytes.

Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN, Qin H.

J Immunol. 2010 May 1;184(9):4898-906. doi: 10.4049/jimmunol.1000142. Epub 2010 Mar 29.

2.

TGF-beta promotes Th17 cell development through inhibition of SOCS3.

Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, Reynolds SL, Weaver CT, Roarty K, Serra R, Benveniste EN, Cong Y.

J Immunol. 2009 Jul 1;183(1):97-105. doi: 10.4049/jimmunol.0801986. Epub 2009 Jun 17.

3.

Regulation of CCL20 expression in astrocytes by IL-6 and IL-17.

Meares GP, Ma X, Qin H, Benveniste EN.

Glia. 2012 May;60(5):771-81. doi: 10.1002/glia.22307. Epub 2012 Feb 8.

PMID:
22319003
4.

Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.

Baker BJ, Qin H, Benveniste EN.

Glia. 2008 Aug 15;56(11):1250-62. doi: 10.1002/glia.20694.

5.

Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia.

Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, Benveniste EN.

J Immunol. 2007 Nov 1;179(9):5966-76.

6.

Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.

Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F.

J Immunol. 2002 Jun 15;168(12):6404-11.

7.
8.

Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo.

Yang XP, Schaper F, Teubner A, Lammert F, Heinrich PC, Matern S, Siewert E.

J Hepatol. 2005 Oct;43(4):704-10.

PMID:
16040151
9.

Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling.

Jackson SH, Yu CR, Mahdi RM, Ebong S, Egwuagu CE.

J Immunol. 2004 Feb 15;172(4):2307-15.

10.

The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa B.

Bode JG, Fischer R, Häussinger D, Graeve L, Heinrich PC, Schaper F.

J Immunol. 2001 Aug 1;167(3):1469-81.

12.

Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.

Downer EJ, Johnston DG, Lynch MA.

Mol Cell Neurosci. 2013 Sep;56:148-58. doi: 10.1016/j.mcn.2013.04.007. Epub 2013 May 7.

PMID:
23659921
13.
14.

IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.

Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3356-65. Epub 2007 Oct 5.

15.

The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Davis RL, Das S, Thomas Curtis J, Stevens CW.

Eur J Pharmacol. 2015 Sep 5;762:193-201. doi: 10.1016/j.ejphar.2015.05.040. Epub 2015 May 22.

16.

Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.

Barclay JL, Anderson ST, Waters MJ, Curlewis JD.

Mol Endocrinol. 2007 Oct;21(10):2503-15. Epub 2007 Jul 3.

PMID:
17609438
17.

Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads.

Tanaka K, Ichiyama K, Hashimoto M, Yoshida H, Takimoto T, Takaesu G, Torisu T, Hanada T, Yasukawa H, Fukuyama S, Inoue H, Nakanishi Y, Kobayashi T, Yoshimura A.

J Immunol. 2008 Mar 15;180(6):3746-56.

18.

Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.

Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H.

Nat Med. 2006 Jul;12(7):829-34. Epub 2006 Jun 18.

PMID:
16783372
19.

Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.

Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN.

J Neurosci. 1999 Jul 1;19(13):5236-44.

20.

IL-6 induces NF-kappa B activation in the intestinal epithelia.

Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, Sitaraman SV.

J Immunol. 2003 Sep 15;171(6):3194-201.

Supplemental Content

Support Center